We don't wanna risk sarcopenic obesity in their future because they lose muscle mass just to try to manage endometriosis
When consumers stop a GLP-1 drug, the health benefits experienced are often eroded: a preliminary study showed that those who stopped taking GLP-1 prescriptions on average gained two thirds of lost weight back, diminishing the health benefits of the drugs over time
Here are the most frequent mistakes and their fixes
For instance, Alami et al
The secondary endpoint of fibrosis reduction by at least one stage was documented in 34%, 36%, and 34% of participants receiving survodutide compared to 22% of placebo, demonstrating potential anti-fibrotic benefit [23]
Body composition changes depend on starting weight, age, sex hormones, baseline fat distribution, genetics, and treatment duration